Charlotte J. Haug, M .D., Ph.D.1 The retractions came only weeks after BioMed Central, an open-access publisher also owned by Springer, retracted 43 content articles for the same reason. […]

Gunter von Minckwitz, M.D., Holger Eidtmann, M.D., Mahdi Rezai, M.D., Peter A. Fasching, M.D., Hans Tesch, M.D., Holm Eggemann, M.D., Iris Schrader, M.D., Kornelia Kittel, M.D., Claus Hanusch, M.D., Rolf […]

This article was reprinted from Genetic Engineering & Biotechnology Information with permission from Mary Ann Liebert, Inc., publishers. Genetic Engineering & Biotechnology Information has retained its position as the number […]

AcelRx reports revenue of $408,000 for third quarter 2011 AcelRx Pharmaceuticals, Inc. , , a specialty pharmaceutical company focused on the advancement and commercialization of innovative therapies for the treatment […]

‘Thanks to Aflac’s campaign to raise money for childhood malignancy and blood disorders on Causes on Facebook, children at the Aflac Malignancy Center will be assured cutting edge treatment and […]

Family and Individual Strategy Segment and the Emerging Markets Segment. Additionally, he has served as the business merger and acquisition business lead for many of Cigna's acquisitions/partnerships, such as for […]

1 .5 million children struggling from diarrhoea can be saved every full year with the right treatment Despite global efforts to regulate it, diarrhoea continues to be probably the […]